Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 Adj. EBITDA Up At SEK 15.4 Mln

April 25 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * Q1 ADJUSTED EBITDA SEK 15.4 MILLION VERSUS PROFIT SEK 6.3 MILLION YEAR AGO
    * Q1 NET SALES SEK 92.7 MILLION VERSUS SEK 58.3 MILLION YEAR AGO

Source text for Eikon:  ID:nMFN3dw2Ns 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news